RVTY · Revvity, Inc.
$110.47
+3.18% last session
End-of-day data · updated 2026-07-28
Market cap
$12B
Enterprise value
$15B
Trailing P/E
52.0
Forward P/E
18.5
Dividend yield
0.0%
Beta
1.09
Avg volume
1M
Employees
11K
2D change
—
5D change
-4.51%
10D change
-1.89%
30D change
-4.32%
60D change
3.43%
MTD change
-4.17%
YTD change
11.93%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — RVTY
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-06
Latest call per bank · past 12 months
Barclays
Equal-Weight$105
-5.0% vs priceJP Morgan
Neutral$90.00
-18.5% vs priceGoldman Sachs
Neutral$95.00
-14.0% vs priceWells Fargo
Equal-Weight$110
-0.4% vs priceJefferies
Hold$105
-5.0% vs priceBank of America
Buy$99.00
-10.4% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-06 | Evercore ISI Group | Maintains | Outperform | $110 → $125 |
| 2026-05-07 | Barclays | Maintains | Equal-Weight | $95.00 → $105 |
| 2026-05-06 | JP Morgan | Maintains | Neutral | $96.00 → $90.00 |
| 2026-05-06 | TD Cowen | Maintains | Buy | $115 → $120 |
| 2026-05-06 | Stifel | Maintains | Hold | $110 → $100 |
| 2026-05-04 | Baird | Maintains | Outperform | $129 → $125 |
| 2026-04-14 | Goldman Sachs | Maintains | Neutral | $110 → $95.00 |
| 2026-04-14 | Barclays | Downgrade | Overweight → Equal-Weight | $118 → $95.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 55 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 6.6% above the 50-day MA ($104.60).
- Price vs 200-day MA: Trading 13.4% above the 200-day MA ($98.35).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.55) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($82.21) and high ($117.58).
RVTY Price Chart
Loading chart for RVTY…
Fundamentals
About Revvity, Inc.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
More in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
$208B -3.3% YTD
DHR
Danaher Corporation
$138B -13.8% YTD
IDXX
IDEXX Laboratories, Inc.
$44B -17.8% YTD
A
Agilent Technologies, Inc.
$39B 1.9% YTD
NTRA
Natera, Inc.
$37B 12.6% YTD
IQV
IQVIA Holdings, Inc.
$36B -5.4% YTD
WAT
Waters Corporation
$36B -2.3% YTD
ILMN
Illumina, Inc.
$29B 44.5% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.